Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.[citation needed]
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange.
Cellvizio technology generates cellular images using a small, flexible microscope, providing clinicians with microscopic images of tissue in a minimally-invasive manner. A real-time image processing software combined with a high-speed Laser Scanning Unit (LSU) allows Cellvizio to produce images at 12 frames per second.
Confocal Imaging Cellvizio belongs to a specific category of microscopes, called confocal laser microscopes.
Timelineedit
History
2000
Founding of Mauna Kea Technologies
2005
Cellvizio pCLE system receives U.S. Food and Drug Administration (FDA) clearance and CE mark in the European Union
2008
Cellvizio named runner-up in the medical device category of The Wall Street Journal's 2008 Technology Innovation Awards [1]
2010
Cellvizio systems installed in over 180 hospitals and research centers worldwide
2011
Launch of Cellvizio 100 Series; Initial Public Offering
2016
Cellvizio receives FDA clearance for near-infrared surgical miniprobes[2]
2017
Cellvizio receives FDA 510(K) Clearance in the US and CE mark in Europe to be used during robot-assisted surgeries[3]
2017
Cellvizio CLE receives 14th U.S. Food and Drug Administration (FDA) clearance[4]
2018
Cellvizio receives reimbursement clearance in South Korea [5]
2018
Cellvizio technology used to discover new human organ “interstitium” [6]
2018
Cellvizio CLE system received FDA clearance for use in neurosurgery [7]
Recent discoveriesedit
Cellvizio probe-based confocal laser endomicroscopy technology or pCLE was instrumental in discovering the interstitium, a contiguous fluid-filled space existing between a structural barrier, such as a cell wall or the skin, and internal structures, such as organs, including muscles and the circulatory system. It is located in the submucosa that drains fluid into lymph nodes and is supported by collagen bundles. Researchers believe that this organ could be important in a number of pathological conditions including cancer metastasis, tissue edema and fibrosis, and has the potential of being the largest "organ" in the human body. Findings from the study co-led by an NYU Langone Health and Mount Sinai Beth were published in the March 27, 2018 issue of the peer-reviewed journal Scientific Reports[8][9]
Referencesedit
^Wall Street Journal: The 2008 Technology Innovation Awards
^Benias, Petros C.; Wells, Rebecca G.; Sackey-Aboagye, Bridget; Klavan, Heather; Reidy, Jason; Buonocore, Darren; Miranda, Markus; Kornacki, Susan; Wayne, Michael; Carr-Locke, David L.; Theise, Neil D. (2018). "Structure and Distribution of an Unrecognized Interstitium in Human Tissues". Scientific Reports. 8 (1): 4947. doi:10.1038/s41598-018-23062-6. PMC5869738. PMID 29588511.
^Scientific American: Meet Your Interstitium, a Newfound "Organ"
April 12, 2024
mauna, technologies, global, medical, device, company, focused, endomicroscopy, field, microscopic, imaging, during, endoscopy, procedures, company, researches, develops, markets, tools, visualize, detect, rule, abnormalities, including, malignant, malignant, . Mauna Kea Technologies is a global medical device company focused on endomicroscopy the field of microscopic imaging during endoscopy procedures The company researches develops and markets tools to visualize detect and rule out abnormalities including malignant and pre malignant tumors or lesions in the gastrointestinal and pulmonary tracts Mauna Kea Technologies S A Company typePublic Societe Anonyme Traded asEuronext Paris MKEAISINFR0010609263IndustryMedical TechnologyFounded2000HeadquartersParis FranceKey peopleRobert Gershon CEO Sacha Loiseau FounderProductsCellvizioNumber of employees120Websitewww maunakeatech comThe company makes Cellvizio a probe based Confocal Laser Endomicroscopy pCLE system which provides physicians and researchers with real time access to histological information during standard endoscopy procedures through high resolution cellular imaging of internal tissues citation needed Cellvizio is used in medical applications such as gastrointestinal endoscopy pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real time Cellvizio went public in July 2011 and trades on the Euronext Paris exchange Contents 1 Cellvizio Technology 2 Timeline 3 Recent discoveries 4 ReferencesCellvizio Technology editCellvizio technology generates cellular images using a small flexible microscope providing clinicians with microscopic images of tissue in a minimally invasive manner A real time image processing software combined with a high speed Laser Scanning Unit LSU allows Cellvizio to produce images at 12 frames per second Confocal Imaging Cellvizio belongs to a specific category of microscopes called confocal laser microscopes Timeline editHistory2000 Founding of Mauna Kea Technologies2005 Cellvizio pCLE system receives U S Food and Drug Administration FDA clearance and CE mark in the European Union2008 Cellvizio named runner up in the medical device category of The Wall Street Journal s 2008 Technology Innovation Awards 1 2010 Cellvizio systems installed in over 180 hospitals and research centers worldwide2011 Launch of Cellvizio 100 Series Initial Public Offering2016 Cellvizio receives FDA clearance for near infrared surgical miniprobes 2 2017 Cellvizio receives FDA 510 K Clearance in the US and CE mark in Europe to be used during robot assisted surgeries 3 2017 Cellvizio CLE receives 14th U S Food and Drug Administration FDA clearance 4 2018 Cellvizio receives reimbursement clearance in South Korea 5 2018 Cellvizio technology used to discover new human organ interstitium 6 2018 Cellvizio CLE system received FDA clearance for use in neurosurgery 7 Recent discoveries editCellvizio probe based confocal laser endomicroscopy technology or pCLE was instrumental in discovering the interstitium a contiguous fluid filled space existing between a structural barrier such as a cell wall or the skin and internal structures such as organs including muscles and the circulatory system It is located in the submucosa that drains fluid into lymph nodes and is supported by collagen bundles Researchers believe that this organ could be important in a number of pathological conditions including cancer metastasis tissue edema and fibrosis and has the potential of being the largest organ in the human body Findings from the study co led by an NYU Langone Health and Mount Sinai Beth were published in the March 27 2018 issue of the peer reviewed journal Scientific Reports 8 9 References edit Wall Street Journal The 2008 Technology Innovation Awards PR Newswire Press Release Market Watch Press Release Markets Insider Press Release New York Business Journals Press Release Live Science Meet your new found organ https www livescience com 62128 interstitium organ html Bio Optics World Press Release Benias Petros C Wells Rebecca G Sackey Aboagye Bridget Klavan Heather Reidy Jason Buonocore Darren Miranda Markus Kornacki Susan Wayne Michael Carr Locke David L Theise Neil D 2018 Structure and Distribution of an Unrecognized Interstitium in Human Tissues Scientific Reports 8 1 4947 doi 10 1038 s41598 018 23062 6 PMC 5869738 PMID 29588511 Scientific American Meet Your Interstitium a Newfound Organ Retrieved from https en wikipedia org w index php title Mauna Kea Technologies amp oldid 1194850750, wikipedia, wiki, book, books, library,
